Second-generation antihistamines: the risk of ventricular arrhythmias.

DuBuske, L M

DuBuske, L M.

Affiliation

DuBuske LM; Brigham and Women's Hospital, Boston, Massachusetts, USA.

Clin Ther ; 21(2): 281-95, 1999 Feb.

Article in En | MEDLINE | ID: mdl-10211532

Subject(s)

Heart/drug effects; Histamine H1 Antagonists/adverse effects; Tachycardia, Ventricular/chemically induced; Animals; Astemizole/adverse effects; Astemizole/metabolism; Astemizole/pharmacokinetics; Cytochrome P-450 Enzyme System; Drug Interactions; Electrocardiography; Histamine H1 Antagonists/metabolism; Histamine H1 Antagonists/pharmacokinetics; Humans; Myocardium/metabolism; Potassium Channels; Risk; Terfenadine/adverse effects; Terfenadine/metabolism; Terfenadine/pharmacokinetics; Torsades de Pointes/chemically induced

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Tachycardia, Ventricular / Heart / Histamine H1 Antagonists Type of study: Etiology_studies / Risk_factors_studies Limits: Animals / Humans Language: En Journal: Clin Ther Year: 1999 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links